NCT07575815 Baseline Anxiety Trajectories in Pediatric Radiation Therapy Observational Cohort
| NCT ID | NCT07575815 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Anxiety |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-05-06 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2026-05-06 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective, observational cohort study of pediatric patients ages 2-12 undergoing radiation therapy at MD Anderson Cancer Center.
Eligibility Criteria
Inclusion Criteria: To be eligible to participate in this study, an individual must meet all of the following criteria: * Provision of signed and dated informed consent from a parent or legal guardian. * For children age 7 and older, provision of informed assent in addition to parental consent, consistent with institutional guidelines. * Stated willingness of parent/guardian and child (as appropriate) to comply with study procedures (i.e., observation during scheduled radiation therapy appointments). * Male or female, ages 2-12 years. * Scheduled to undergo radiation therapy at MD Anderson Cancer Center. Exclusion Criteria: An individual who meets any of the following criteria will be excluded from participation in this study: * Has already completed the simulation session for radiation therapy prior to enrollment. * Declines parental consent or, when applicable, child assent.
Contact & Investigator
Susan L McGovern, MD, PHD
PRINCIPAL INVESTIGATOR
UT MD Anderson
Frequently Asked Questions
Who can join the NCT07575815 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, up to 12 Years, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07575815 currently recruiting?
Yes, NCT07575815 is actively recruiting participants. Contact the research team at slmcgove@mdanderson.org for enrollment information.
Where is the NCT07575815 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT07575815 clinical trial?
NCT07575815 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Susan L McGovern, MD, PHD at UT MD Anderson. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.